RXO RXO INC revenue, earnings and financials

For the quarter ended June 30, 2026, RXO INC reported revenue of $1.77B (up 25.0% from a year earlier), net income of −$9.00M and diluted EPS of −$0.05; over the last four quarters revenue was $6.09B and net income −$105M; for the fiscal year ended December 2025 revenue was $5.74B, up 26.2% on the year before.

RXO annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $5.74B, gross profit n/a, operating income −$79.0M, net income −$100M (margin -1.7%), EPS −$0.59
• Fiscal year ended Dec 2024: revenue $4.55B, gross profit n/a, operating income −$56.0M, net income −$290M (margin -6.4%), EPS −$2.17
• Fiscal year ended Dec 2023: revenue $3.93B, gross profit n/a, operating income $39.0M, net income $4.00M (margin 0.1%), EPS $0.03
• Fiscal year ended Dec 2022: revenue $4.80B, gross profit n/a, operating income $123M, net income $92.0M (margin 1.9%), EPS $0.79
• Fiscal year ended Dec 2021: revenue $4.69B, gross profit n/a, operating income $192M, net income $150M (margin 3.2%), EPS $1.30

RXO quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $1.77B (up 25.0% year over year), net income −$9.00M, EPS −$0.05
• Quarter ended Mar 31, 2026: revenue $1.43B (down 0.6% year over year), net income −$36.0M, EPS −$0.21
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.47B (down 11.9% year over year), net income −$46.0M, EPS −$0.28
• Quarter ended Sep 30, 2025: revenue $1.42B (up 36.6% year over year), net income −$14.0M, EPS −$0.08
• Quarter ended Jun 30, 2025: revenue $1.42B (up 52.6% year over year), net income −$9.00M, EPS −$0.05
• Quarter ended Mar 31, 2025: revenue $1.43B (up 57.0% year over year), net income −$31.0M, EPS −$0.18
• Quarter ended Dec 31, 2024 (from the annual report): revenue $1.67B (up 70.4% year over year), net income −$25.0M, EPS −$0.17
• Quarter ended Sep 30, 2024: revenue $1.04B (up 6.6% year over year), net income −$243M, EPS −$1.81
• Quarter ended Jun 30, 2024: revenue $930M (down 3.4% year over year), net income −$7.00M, EPS −$0.06
• Quarter ended Mar 31, 2024: revenue $913M (down 9.6% year over year), net income −$15.0M, EPS −$0.13
• Quarter ended Dec 31, 2023 (from the annual report): revenue $978M (down 12.7% year over year), net income $2.00M, EPS $0.01
• Quarter ended Sep 30, 2023: revenue $976M (down 14.2% year over year), net income −$1.00M, EPS −$0.01
• Quarter ended Jun 30, 2023: revenue $963M (down 21.5% year over year), net income $3.00M, EPS $0.03
• Quarter ended Mar 31, 2023: revenue $1.01B (down 23.0% year over year), net income $0, EPS $0.00
• Quarter ended Dec 31, 2022 (from the annual report): revenue $1.12B, net income −$4.00M, EPS −$0.04
• Quarter ended Sep 30, 2022: revenue $1.14B (down 5.0% year over year), net income $13.0M, EPS $0.11
• Quarter ended Jun 30, 2022: revenue $1.23B, net income $44.0M, EPS $0.38
• Quarter ended Mar 31, 2022: revenue $1.31B, net income $39.0M, EPS $0.34
• Quarter ended Sep 30, 2021: revenue $1.20B, net income $33.0M, EPS $0.29

RXO cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $51.0M, share buybacks $0
• Fiscal year ended Dec 2024: operating cash flow −$12.0M, share buybacks $0
• Fiscal year ended Dec 2023: operating cash flow $89.0M, share buybacks $2.00M
• Fiscal year ended Dec 2022: operating cash flow $310M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $155M, share buybacks $0

RXO balance sheet

• Jun 30, 2026: cash $15.0M, total assets $3.46B, total liabilities n/a, shareholders' equity $1.51B
• Mar 31, 2026: cash $21.0M, total assets $3.27B, total liabilities n/a, shareholders' equity $1.51B
• Dec 31, 2025: cash $17.0M, total assets $3.28B, total liabilities n/a, shareholders' equity $1.54B
• Sep 30, 2025: cash $25.0M, total assets $3.20B, total liabilities n/a, shareholders' equity $1.58B
• Jun 30, 2025: cash $18.0M, total assets $3.20B, total liabilities n/a, shareholders' equity $1.59B
• Mar 31, 2025: cash $16.0M, total assets $3.30B, total liabilities n/a, shareholders' equity $1.59B
• Dec 31, 2024: cash $35.0M, total assets $3.41B, total liabilities n/a, shareholders' equity $1.61B
• Sep 30, 2024: cash $55.0M, total assets $3.39B, total liabilities n/a, shareholders' equity $1.65B

What is RXO's revenue?

RXO INC reported $6.09B of revenue over its last four quarters, through June 30, 2026.

Is RXO profitable?

No. RXO INC lost $105M over the last four quarters.

What is RXO's EPS?

Diluted earnings per share over the last four quarters were −$0.62; −$0.05 in the latest quarter.

RXO ownership and insider trades · All stocks